Company intelligence / Profile preview

BioPharma Credit Investments V

George Town, Cayman Islands

Ownership: Private
Development stage: Other

Overview

BioPharma Credit Investments V is a Cayman Islands-based investment partnership providing capital to the life sciences sector, generally through senior secured loans and royalty-backed debt, with no direct clinical programs or clinical results of its own, but recent activities include a $25 million investment as part of a $275 million senior secured loan to Paratek Pharmaceuticals.

Industry: Investors

Partnerships

Pharmakon AdvisorsBioPharma Credit PLCOaktree Capital ManagementQ Aspen LLC (Qatar Investment Authority)

Beyond the preview

Go deeper on BioPharma Credit Investments V.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioPharma Credit Investments V.

Explore the full profile